{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:39:49Z","timestamp":1773297589400,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-2623-3","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T15:53:46Z","timestamp":1451404426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?"],"prefix":"10.1186","volume":"15","author":[{"given":"Hossein","family":"Khosravi-Boroujeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Talaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Dianatkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Pourmogaddas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"issue":"25","key":"2623_CR1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Panel NCEPNE","year":"2002","unstructured":"Panel NCEPNE. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"6","key":"2623_CR2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Horton JD, Cohen JC, Grundy SM, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387\u201395.","journal-title":"Hepatology"},{"issue":"31","key":"2623_CR3","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.3748\/wjg.v18.i31.4215","volume":"18","author":"L-Y Chen","year":"2012","unstructured":"Chen L-Y, Qiao Q-H, Zhang S-C, Chen Y-H, Chao G-Q, Fang L-Z. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012;18(31):4215\u201320.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2623_CR4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"S Lim","year":"2012","unstructured":"Lim S, Davies M, Norman R, Moran L. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"2623_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ehj.2004.02.021","volume":"25","author":"SR Coughlin","year":"2004","unstructured":"Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735\u201341.","journal-title":"Eur Heart J"},{"issue":"10","key":"2623_CR6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik S, Wong ND, Franklin SS, Kamath TV, Gilbert J, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245\u201350.","journal-title":"Circulation"},{"issue":"1","key":"2623_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-14-9","volume":"14","author":"JV Vliet-Ostaptchouk van","year":"2014","unstructured":"van Vliet-Ostaptchouk JV, Nuotio M-L, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14(1):9.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2623_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2471\/BLT.07.049841","volume":"87","author":"N Sarrafzadegan","year":"2009","unstructured":"Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, Mohammadifard N, Rabiei K, Roohafza H, et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87(1):39\u201350.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2623_CR9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/dc08-1800","volume":"32","author":"A Delavari","year":"2009","unstructured":"Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"2623_CR10","first-page":"138","volume":"16","author":"M Nizal Sarrafzadegan","year":"2013","unstructured":"Nizal Sarrafzadegan M, Sadeghi M, Shahram Oveisgharan M, Marshall T. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013;16(3):138\u201344.","journal-title":"Arch Iran Med"},{"issue":"16","key":"2623_CR11","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"K Alberti","year":"2009","unstructured":"Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. International diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; international association for the study of obesity. harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"key":"2623_CR12","volume-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, vol. 1","author":"World Health Organization","year":"1999","unstructured":"World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, vol. 1. Geneva: World Health Organization; 1999."},{"key":"2623_CR13","unstructured":"International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Brussels, Belgium: IDF Communications; 2006. http:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf ."},{"issue":"19","key":"2623_CR14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection E","year":"2001","unstructured":"Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"5","key":"2623_CR15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/jwh.2007.0536","volume":"17","author":"TM Brown","year":"2008","unstructured":"Brown TM, Vaidya D, Rogers WJ, Waters DD, Howard BV, Tardif J-C, et al. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health. 2008;17(5):841\u20137.","journal-title":"J Womens Health"},{"issue":"9","key":"2623_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/jhh.2010.99","volume":"25","author":"N Sarrafzadegan","year":"2010","unstructured":"Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, et al. The Isfahan cohort study: Rationale, methods and main findings. J Hum Hypertens. 2010;25(9):545\u201353.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2623_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(87)90188-4","volume":"166","author":"JR McNamara","year":"1987","unstructured":"McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chem Acta. 1987;166(1):1\u20138.","journal-title":"Clin Chem Acta"},{"issue":"2","key":"2623_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/clinchem\/31.2.217","volume":"31","author":"G Warnick","year":"1985","unstructured":"Warnick G, Nguyen T, Albers A. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985;31(2):217\u201322.","journal-title":"Clin Chem"},{"issue":"6","key":"2623_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"5","key":"2623_CR20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"Balkau B, Charles M-A. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16(5):442\u20133.","journal-title":"Diabet Med"},{"issue":"5","key":"2623_CR21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"K Alberti","year":"2006","unstructured":"Alberti K, Zimmet P, Shaw J. Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469\u201380.","journal-title":"Diabet Med"},{"issue":"17","key":"2623_CR22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American heart association\/national heart, lung, and blood institute scientific statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"8","key":"2623_CR23","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jacc.2005.11.074","volume":"47","author":"Y He","year":"2006","unstructured":"He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol. 2006;47(8):1588\u201394.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2623_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2004.03.002","volume":"33","author":"G Reaven","year":"2004","unstructured":"Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33(2):283\u2013303.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2623_CR25","first-page":"S16","volume":"19","author":"R Eckel","year":"1995","unstructured":"Eckel R, Yost T, Jensen D. Alterations in lipoprotein lipase in insulin resistance. Int J Obes Relat Metab Disord. 1995;19:S16\u201321.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"2623_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","volume":"317","author":"E Ferrannini","year":"1987","unstructured":"Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317(6):350\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"2623_CR27","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/diabetes.53.8.2087","volume":"53","author":"DB Carr","year":"2004","unstructured":"Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087\u201394.","journal-title":"Diabetes"},{"issue":"3","key":"2623_CR28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.26.3.650","volume":"26","author":"T Hayashi","year":"2003","unstructured":"Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity and the risk of impaired glucose tolerance a prospective study among Japanese Americans. Diabetes Care. 2003;26(3):650\u20135.","journal-title":"Diabetes Care"},{"issue":"11","key":"2623_CR29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0026-0495(03)00257-9","volume":"52","author":"C Rattarasarn","year":"2003","unstructured":"Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W, Thamprasit A, Lim A, et al. Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors. Metabolism. 2003;52(11):1444\u20137.","journal-title":"Metabolism"},{"issue":"5","key":"2623_CR30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/diacare.26.5.1413","volume":"26","author":"BJ Nicklas","year":"2003","unstructured":"Nicklas BJ, Penninx BW, Ryan AS, Berman DM, Lynch NA, Dennis KE. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care. 2003;26(5):1413\u201320.","journal-title":"Diabetes Care"},{"key":"2623_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1096-6374(98)80018-X","volume":"8","author":"B Lamarche","year":"1998","unstructured":"Lamarche B, Lemieux S, Dagenais G, Despr\u00e9s J-P. Visceral obesity and the risk of ischaemic heart disease: insights from the Quebec Cardiovascular Study. Growth Horm IGF Res. 1998;8:1\u20138.","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"2623_CR32","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2337\/diabetes.51.7.2029","volume":"51","author":"V Harmelen van","year":"2002","unstructured":"van Harmelen V, Dicker A, Ryd\u00e9n M, Hauner H, L\u00f6nnqvist F, N\u00e4slund E, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes. 2002;51(7):2029\u201336.","journal-title":"Diabetes"},{"issue":"10","key":"2623_CR33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0026-0495(03)00195-1","volume":"52","author":"T Yatagai","year":"2003","unstructured":"Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism. 2003;52(10):1274\u20138.","journal-title":"Metabolism"},{"issue":"6","key":"2623_CR34","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1210\/jc.2003-031843","volume":"89","author":"N Abate","year":"2004","unstructured":"Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab. 2004;89(6):2750\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2623_CR35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","volume":"27","author":"C-E Tan","year":"2004","unstructured":"Tan C-E, Ma S, Wai D, Chew S-K, Tai E-S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27(5):1182\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"2623_CR36","first-page":"243","volume":"13","author":"M Fereidoun Azizi","year":"2010","unstructured":"Fereidoun Azizi M, Davood Khalili M, Hassan Aghajani M, Alireza Esteghamati M, Farhad Hosseinpanah M, Alireza Delavari M, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(3):243.","journal-title":"Arch Iran Med"},{"issue":"2","key":"2623_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.diabres.2006.12.001","volume":"77","author":"A Zabetian","year":"2007","unstructured":"Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251\u20137.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2623_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-8227(03)00066-4","volume":"61","author":"F Azizi","year":"2003","unstructured":"Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003;61(1):29\u201337.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2623_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2007.10.049","volume":"131","author":"N Sarrafzadegan","year":"2008","unstructured":"Sarrafzadegan N, Kelishadi R, Baghaei A, Sadri GH, Malekafzali H, Mohammadifard N, et al. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program. Int J Cardiol. 2008;131(1):90\u20136.","journal-title":"Int J Cardiol"},{"issue":"3","key":"2623_CR40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.diabres.2007.02.002","volume":"77","author":"AJ Cameron","year":"2007","unstructured":"Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract. 2007;77(3):471\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2623_CR41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","volume":"24","author":"B Isomaa","year":"2001","unstructured":"Isomaa B, Almgren P, Tuomi T, Fors\u00e9n B, Lahti K, Niss\u00e9n M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683\u20139.","journal-title":"Diabetes Care"},{"issue":"2","key":"2623_CR42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2003.09.028","volume":"93","author":"CJ Girman","year":"2004","unstructured":"Girman CJ, Rhodes T, Mercuri M, Py\u00f6r\u00e4l\u00e4 K, Kjekshus J, Pedersen TR, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force\/Texas coronary atherosclerosis prevention study (AFCAPS\/TexCAPS). Am J Cardiol. 2004;93(2):136\u201341.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2623_CR43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ehj.2003.12.007","volume":"25","author":"JK Olijhoek","year":"2004","unstructured":"Olijhoek JK, van der Graaf Y, Banga J-D, Algra A, Rabelink TJ, Visseren FL. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25(4):342\u20138.","journal-title":"Eur Heart J"},{"issue":"14","key":"2623_CR44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2623_CR45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","volume":"49","author":"AS Gami","year":"2007","unstructured":"Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2623_CR46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","volume":"119","author":"A Galassi","year":"2006","unstructured":"Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812\u20139.","journal-title":"Am J Med"},{"issue":"7","key":"2623_CR47","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2337\/diabetes.53.7.1782","volume":"53","author":"E Bonora","year":"2004","unstructured":"Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Population-based incidence rates and risk factors for type 2 diabetes in White individuals The Bruneck Study. Diabetes. 2004;53(7):1782\u20139.","journal-title":"Diabetes"},{"issue":"5\u20136","key":"2623_CR48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Mode Mech. 2009;2(5\u20136):231\u20137.","journal-title":"Dis Mode Mech"},{"issue":"3","key":"2623_CR49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-J\u00e4rvinen H, Van Haeften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295\u2013301.","journal-title":"Diabetes Care"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-2623-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T09:33:38Z","timestamp":1599989618000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2458\/15\/1313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-2623-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"1313"}}